C
EW icon

Certuity’s Edwards Lifesciences EW Stock Holding History

Certuity’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$260K Buy
3,247
+894
+38% +$73.7K 0.02% 511
2025
Q4 		$201K Buy
+2,353
New +$193K 0.01% 557
2025
Q1 		– Sell
-3,128
Closed -$232K – 415
2024
Q4 		$232K Buy
+3,128
New +$219K 0.03% 322
2023
Q3 		– Sell
-3,243
Closed -$306K – 274
2023
Q2 		$306K Sell
3,243
-191
-6% -$16.6K 0.03% 197
2023
Q1 		$284K Buy
+3,434
New +$270K 0.04% 169
2022
Q4 		– Sell
-2,933
Closed -$242K – 224
2022
Q3 		$242K Sell
2,933
-167
-5% -$16.1K 0.06% 159
2022
Q2 		$295K Buy
3,100
+119
+4% +$12.3K 0.08% 150
2022
Q1 		$351K Buy
2,981
+420
+16% +$47.1K 0.08% 182
2021
Q4 		$332K Sell
2,561
-216
-8% -$25.2K 0.07% 190
2021
Q3 		$314K Sell
2,777
-574
-17% -$65.5K 0.06% 265
2021
Q2 		$347K Buy
3,351
+392
+13% +$37K 0.08% 194
2021
Q1 		$247K Buy
2,959
+469
+19% +$39.6K 0.07% 246
2020
Q4 		$227K Buy
+2,490
New +$207K 0.07% 201
2020
Q1 		– Sell
-855
Closed -$66K – 193
2019
Q4 		$66K Buy
+855
New +$66.8K 0.03% 184

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Certuity's EW Position: Q1 2026 in Review

Certuity increased its Edwards Lifesciences (EW) stake by 38% in Q1 2026, buying an estimated $73.7K and bringing the position to 3,247 shares worth $260K. The position accounts for 0.02% of the portfolio, ranked #511.

Certuity first reported a position in EW in Q4 2019 and has held it in 14 quarters since. The position peaked at $351K in Q1 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Certuity held 3,247 shares of Edwards Lifesciences worth $260K as of Q1 2026.
  • Certuity bought 894 Edwards Lifesciences shares in Q1 2026, an estimated $73.7K.
  • Edwards Lifesciences made up 0.02% of Certuity's portfolio in Q1 2026, its #511 holding.
  • Certuity first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 14 quarters since.
  • Certuity's Edwards Lifesciences position peaked at $351K in Q1 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Certuity's 13F filing for Q1 2026, filed 11 May 2026.